nucleocapsid

RSV604 ((S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea) 是一种呼吸道合胞病毒抑制剂，可与 RSV 核蛋白结合，靶向核衣壳蛋白的 Kd 值为 1.6 μM。它对 RSV A 和 B 亚型的众多临床分离株有亚微摩尔活性，EC50平均值为 0.8 μM。

BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM).

GLP-26 是一种HBV 衣壳组装调节剂，抑制 Hep AD38 系统中的 HBV DNA 复制，IC50值为3 nM。 在 1 μM 时，使 cccDNA 降低> 90％。它破坏前基因组 RNA 的衣壳化，导致核衣壳解体，并减少 cccDNA 库。

The nucleocapsid of the hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. The four major subtypes of HBsAg, adw, adr, ayw and ayr, are generated, and they have been proposed to

SAMT-247 is an HIV inhibitor that acts by modifying the nucleocapsid NCp7 region of Gag in infected cells and blocking Gag processing and reducing infectivity.

5-Benzyloxygramine 是一种 N 蛋白、蛋白互作的原位稳定剂，具有抗病毒和稳定 N-NTD 蛋白的作用。它能够阻断多巴胺受体，可拮抗 5-HT 对大鼠子宫和兔耳的作用。

SARS-CoV-2-IN-16 (Compound 12) 是SARS-CoV-2核衣壳蛋白的有效抑制剂，具有强效的抗病毒活性(EC50 = 3.69 μM)。SARS-CoV-2-IN-16 以7.82 μM 的低Kd 值与 NPro 结合，这表明 SARS-CoV-2-IN-16 是一种有效的 NPro 配体。

SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of SARS-CoV-2 nucleocapsid protein (NPro). It demonstrates potent anti-viral activity, with an EC50 value of 2.18 μM. Furthermore, SARS-CoV-2-IN-17 binds to NPro with a low Kd value of 7.82 μM, highlighting its potency as a NPro ligand [1].

Claficapavir (A1752) is a potent nucleocapsid protein (NC) inhibitor that effectively binds the HIV-1 NC with a dissociation constant (Kd) of 20 nM, resulting in the inhibition of its chaperone properties. This specific molecular interaction leads to strong antiviral activity against HIV-1, with an IC50 of approximately 1 μM [1].

PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HIV.

Azodicarbonamide是一个能通过针对nucleocapsid CCHC domains来抑制HIV-1及多种逆转录病毒的核衣壳抑制剂。在标准细胞抗病毒测试中，该化合物能够抑制HIV-1RF引起的CEM-SS细胞病变，其EC50值为38 µM。

HCoV-OC43-IN-1 (Compound IV-16) 为一种针对冠状病毒HCoV-OC43的抑制剂，展现出显著的抗病毒活性 (EC50: 90 nM)，能有效抑制病毒核衣壳蛋白 (NP) 的 mRNA 水平及其表达。

PAV-104 能抑制SARS-CoV-2的复制，MOI为0.01。PAV-104 与SARS-CoV-2 核衣壳 (N) 相互作用，破坏其寡聚化，阻碍病毒颗粒的组装。

CEF4 is a peptide derived from amino acids (aa) 342-351 of the influenza A virus nucleocapsid protein.

CEF4 acetate (CEF4 acetate (199727-68-9 free base)) 是对应于甲型流感病毒核壳蛋白的氨基酸序列342-351的多肽。